Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable CCR2 chemokine receptor binding activity; heparin binding activity; and lipopolysaccharide binding activity. Predicted to be involved in defense response to bacterium and innate immune response. Predicted to be located in membrane; microvesicle; and nucleus. Orthologous to human DEFB106A (defensin beta 106A) and DEFB106B (defensin beta 106B).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.